190 related articles for article (PubMed ID: 22612740)
1. Biochemical markers of autoimmune diseases of the nervous system.
Tumani H; Brettschneider J
Curr Pharm Des; 2012; 18(29):4556-63. PubMed ID: 22612740
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity.
Tan X; Liu Y; Wu X; Guo Y
J Neurol; 2022 Nov; 269(11):5893-5900. PubMed ID: 35781606
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody-mediated disorders of the central nervous system.
Irani S; Lang B
Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
[TBL] [Abstract][Full Text] [Related]
4. Friendly fire on neurons: antibody-mediated diseases of the nervous system.
Chang T
Ceylon Med J; 2015 Dec; 60(4):121-5. PubMed ID: 26778390
[No Abstract] [Full Text] [Related]
5. Systematic review of the clinical spectrum of CASPR2 antibody syndrome.
Boyko M; Au KLK; Casault C; de Robles P; Pfeffer G
J Neurol; 2020 Apr; 267(4):1137-1146. PubMed ID: 31912210
[TBL] [Abstract][Full Text] [Related]
6. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
8. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
[TBL] [Abstract][Full Text] [Related]
9. Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous system.
Antozzi C
Atheroscler Suppl; 2013 Jan; 14(1):219-22. PubMed ID: 23357168
[TBL] [Abstract][Full Text] [Related]
10. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.
Kaneko J; Kanazawa N; Tominaga N; Kaneko A; Suga H; Usui R; Ishima D; Kitamura E; Akutsu T; Yoshida K; Nishiyama K; Iizuka T
J Neurol Sci; 2018 Jul; 390():26-32. PubMed ID: 29801900
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations of patients with CASPR2 antibodies.
Sunwoo JS; Lee ST; Byun JI; Moon J; Shin JW; Jeong DE; Lee GH; Jeong SH; Shin YW; Jung KH; Lee DY; Jeon D; Jung KY; Kim M; Lee SK; Chu K
J Neuroimmunol; 2015 Apr; 281():17-22. PubMed ID: 25867463
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
[No Abstract] [Full Text] [Related]
13. Guillain-Barré syndrome associated with CASPR2 antibodies: two paediatric cases.
Rosch RE; Bamford A; Hacohen Y; Wraige E; Vincent A; Mewasingh L; Lim M
J Peripher Nerv Syst; 2014 Sep; 19(3):246-9. PubMed ID: 25413786
[TBL] [Abstract][Full Text] [Related]
14. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
van Sonderen A; Schreurs MW; de Bruijn MA; Boukhrissi S; Nagtzaam MM; Hulsenboom ES; Enting RH; Thijs RD; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Neurology; 2016 May; 86(18):1692-9. PubMed ID: 27037230
[TBL] [Abstract][Full Text] [Related]
15. New autoantibody mediated disorders of the central nervous system.
Lang B; Dale RC; Vincent A
Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Encephalopathies and Dementias.
McKeon A
Continuum (Minneap Minn); 2016 Apr; 22(2 Dementia):538-58. PubMed ID: 27042907
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies.
Jia Y; Shi H; Ye J; Wang Y
Clin Neurol Neurosurg; 2020 Oct; 197():106187. PubMed ID: 32911250
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.
Joubert B; Saint-Martin M; Noraz N; Picard G; Rogemond V; Ducray F; Desestret V; Psimaras D; Delattre JY; Antoine JC; Honnorat J
JAMA Neurol; 2016 Sep; 73(9):1115-24. PubMed ID: 27428927
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune disorders affecting both the central and peripheral nervous system.
Kamm C; Zettl UK
Autoimmun Rev; 2012 Jan; 11(3):196-202. PubMed ID: 21619947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
